AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
MANAGEMENT OF AN ISOLATED THYMIC MASS AFTER PRIMARY THERAPY FOR LYMPHOMA
Authors: ANCHISI S ABELE R GUETTYALBERTO M ALBERTO P
Citation: S. Anchisi et al., MANAGEMENT OF AN ISOLATED THYMIC MASS AFTER PRIMARY THERAPY FOR LYMPHOMA, Annals of oncology, 9(1), 1998, pp. 95-100
ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY FOR INOPERABLE STAGE-III NON-SMALL-CELL LUNG-CANCER - LONG-TERM RESULTS OF 2 PHASE-II GOTHA TRIALS
Authors: MIRIMANOFF RO MORO D BOLLA M MICHEL G BRAMBILLA C MERMILLOD B MIRALBELL R ALBERTO P
Citation: Ro. Mirimanoff et al., ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY FOR INOPERABLE STAGE-III NON-SMALL-CELL LUNG-CANCER - LONG-TERM RESULTS OF 2 PHASE-II GOTHA TRIALS, International journal of radiation oncology, biology, physics, 42(3), 1998, pp. 487-494
EFFECT OF LOW-DOSE CHEST IRRADIATION BEFORE CHEMOTHERAPY ON THE RATE OF LOCAL FAILURE IN SMALL-CELL LUNG-CANCER
Authors: HOSLI P BONNEFOI H MIRIMANOFF RO MERMILLOD B ALBERTO P
Citation: P. Hosli et al., EFFECT OF LOW-DOSE CHEST IRRADIATION BEFORE CHEMOTHERAPY ON THE RATE OF LOCAL FAILURE IN SMALL-CELL LUNG-CANCER, International journal of radiation oncology, biology, physics, 41(2), 1998, pp. 287-289
TAXOTERE-CISPLATIN (TC) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PROMISING DRUG-COMBINATION
Authors: ROTH AD MAIBACH R MARTINELLI G FAZIO N PAGANI O MORANT R BORNER MM HERRMANN R HONEGGER HP CAVALLI F ALBERTO P CASTIGLIONE M GOLDHIRSCH A
Citation: Ad. Roth et al., TAXOTERE-CISPLATIN (TC) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PROMISING DRUG-COMBINATION, European journal of cancer, 33, 1997, pp. 1245-1245
A DOUBLE-BLIND CROSSOVER STUDY COMPARING PROPHYLACTIC INTRAVENOUS GRANISETRON ALONE OR IN COMBINATION WITH DEXAMETHASONE AS ANTIEMETIC TREATMENT IN CONTROLLING NAUSEA AND VOMITING ASSOCIATED WITH CHEMOTHERAPY
Authors: KIRCHNER V AAPRO M TERREY JP ALBERTO P
Citation: V. Kirchner et al., A DOUBLE-BLIND CROSSOVER STUDY COMPARING PROPHYLACTIC INTRAVENOUS GRANISETRON ALONE OR IN COMBINATION WITH DEXAMETHASONE AS ANTIEMETIC TREATMENT IN CONTROLLING NAUSEA AND VOMITING ASSOCIATED WITH CHEMOTHERAPY, European journal of cancer, 33(10), 1997, pp. 1605-1610
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
FEASIBILITY, TOXICITY, AND ACTIVITY OF LNH84-DERIVED CHEMOTHERAPY IN THE MANAGEMENT OF AGGRESSIVE LYMPHOMAS
Authors: LAURENCET FM ZULIAN GB BAUER J MERMILLOD B ITEN PA ALBERTO P
Citation: Fm. Laurencet et al., FEASIBILITY, TOXICITY, AND ACTIVITY OF LNH84-DERIVED CHEMOTHERAPY IN THE MANAGEMENT OF AGGRESSIVE LYMPHOMAS, American journal of hematology, 55(4), 1997, pp. 199-204
EARLY CARDIAC STRUCTURAL AND FUNCTIONAL ALTERATIONS IN IDDM AND IMPACT OF COMPLICATIONS
Authors: FELICE P STEFANO C MONICA F PIERLUIGI G ALBERTO P MASSIMO P GABRIELE M ROBERTO B LAURA S ALESSANDRA G CRISTINA G GUISEPPE M
Citation: P. Felice et al., EARLY CARDIAC STRUCTURAL AND FUNCTIONAL ALTERATIONS IN IDDM AND IMPACT OF COMPLICATIONS, Diabetes, 46, 1997, pp. 273-273
CHEMOTHERAPY FOR GASTROINTESTINAL CANCER AND NON-SMALL-CELL LUNG-CANCER - A CONTROVERSIAL ISSUE
Authors: FEY MF SAUTER C ALBERTO P
Citation: Mf. Fey et al., CHEMOTHERAPY FOR GASTROINTESTINAL CANCER AND NON-SMALL-CELL LUNG-CANCER - A CONTROVERSIAL ISSUE, Schweizerische medizinische Wochenschrift, 126(20), 1996, pp. 872-878
TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMP HOMA - THE EXPERIENCE OF A GENERAL-HOSPITAL
Authors: LAURENCET FM ZULIAN GB DIETRICH PY ANCHISI S MERMILLOD B ALBERTO P
Citation: Fm. Laurencet et al., TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMP HOMA - THE EXPERIENCE OF A GENERAL-HOSPITAL, Bulletin du cancer, 83(10), 1996, pp. 864-869
INITIAL PROGNOSTIC FACTORS IN SMALL-CELL LUNG-CANCER PATIENTS PREDICTING QUALITY-OF-LIFE DURING CHEMOTHERAPY
Authors: BERNHARD J HURNY C BACCHI M JOSS RA CAVALLI F SENN HJ LEYVRAZ S STAHEL R LUDWIG C ALBERTO P
Citation: J. Bernhard et al., INITIAL PROGNOSTIC FACTORS IN SMALL-CELL LUNG-CANCER PATIENTS PREDICTING QUALITY-OF-LIFE DURING CHEMOTHERAPY, British Journal of Cancer, 74(10), 1996, pp. 1660-1667
VINCRISTINE, ETOPOSIDE, MITOXANTRONE AND PREDNISONE (VEMP) AS FIRST-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE (HD)
Authors: ZULIAN GB MERMILLOD B ITEN PA ALBERTO P
Citation: Gb. Zulian et al., VINCRISTINE, ETOPOSIDE, MITOXANTRONE AND PREDNISONE (VEMP) AS FIRST-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE (HD), European journal of cancer, 31A, 1995, pp. 805-805
PATIENT PREFERENCE OF ANTIEMETIC TREATMENT - A PLACEBO-CONTROLLED, DOUBLE-BLIND COMPARISON OF GRANISETRON WITH GRANISETRON PLUS DEXAMETHASONE
Authors: TERREY JP AAPRO M KIRCHNER V ALBERTO P
Citation: Jp. Terrey et al., PATIENT PREFERENCE OF ANTIEMETIC TREATMENT - A PLACEBO-CONTROLLED, DOUBLE-BLIND COMPARISON OF GRANISETRON WITH GRANISETRON PLUS DEXAMETHASONE, European journal of cancer, 31A, 1995, pp. 895-895
RAPIDLY ALTERNATING COMBINATION OF CISPLATIN-BASED CHEMOTHERAPY AND HYPERFRACTIONATED ACCELERATED RADIOTHERAPY IN SPLIT COURSE FOR STAGE IIIA AND STAGE IIIB NONSMALL CELL LUNG-CANCER - RESULTS OF A PHASE I-II STUDY BY THE GOTHA GROUP
Authors: ALBERTO P MIRIMANOFF RO MERMILLOD B LEYVRAZ S NAGYMIGNOTTE H BOLLA M WELLMANN D MORO D BRAMBILLA E
Citation: P. Alberto et al., RAPIDLY ALTERNATING COMBINATION OF CISPLATIN-BASED CHEMOTHERAPY AND HYPERFRACTIONATED ACCELERATED RADIOTHERAPY IN SPLIT COURSE FOR STAGE IIIA AND STAGE IIIB NONSMALL CELL LUNG-CANCER - RESULTS OF A PHASE I-II STUDY BY THE GOTHA GROUP, European journal of cancer, 31A(3), 1995, pp. 342-348
A EUROPEAN VIEW OF ASCO-95
Authors: ALBERTO P
Citation: P. Alberto, A EUROPEAN VIEW OF ASCO-95, European journal of cancer, 31A(10), 1995, pp. 1592-1593
CLADRIBINE AND TUMOR LYSIS SYNDROME
Authors: ANCHISI S ZULIAN GB DIETRICH PY ALBERTO P
Citation: S. Anchisi et al., CLADRIBINE AND TUMOR LYSIS SYNDROME, European journal of cancer, 31A(1), 1995, pp. 131-132
LYMPHOMA OF UNCERTAIN PHENOTYPE
Authors: ZULIAN GB DIETRICH PY CONNE B ANCHISI S PACHE JC ROUDEN C ALBERTO P
Citation: Gb. Zulian et al., LYMPHOMA OF UNCERTAIN PHENOTYPE, Annals of oncology, 6(8), 1995, pp. 827-832
COMBINED CHEMOTHERAPY AND RADIOTHERAPY, FOLLOWED OR NOT BY SURGERY, IN SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS
Authors: DEPREE C AAPRO MS SPILIOPOULOS A POPOWSKI Y MERMILLOD B MIRIMANOFF RO ALBERTO P
Citation: C. Depree et al., COMBINED CHEMOTHERAPY AND RADIOTHERAPY, FOLLOWED OR NOT BY SURGERY, IN SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS, Annals of oncology, 6(6), 1995, pp. 551-557
EARLY VERSUS LATE ALTERNATING CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
Authors: JOSS RA BACCHI M HURNY C BERNHARD J CERNY T MARTINELLI G LEYVRAZ S SENN HJ STAHEL R SIEGENTHALER P LUDWIG C ALBERTO P
Citation: Ra. Joss et al., EARLY VERSUS LATE ALTERNATING CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Annals of oncology, 6(2), 1995, pp. 157-166
QUALITY VERSUS QUANTITY OF LIFE IN THE TREATMENT OF PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III COMPARISON OF WEEKLY CARBOPLATIN AND TENIPOSIDE VERSUS CISPLATIN, ADRIAMYCIN, ETOPOSIDE ALTERNATING WITH CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE AND LOMUSTINE
Authors: JOSS RA ALBERTO P HURNY C BACCHI M LEYVRAZ S THURLIMANN B CERNY T MARTINELLI G STAHEL R LUDWIG C
Citation: Ra. Joss et al., QUALITY VERSUS QUANTITY OF LIFE IN THE TREATMENT OF PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III COMPARISON OF WEEKLY CARBOPLATIN AND TENIPOSIDE VERSUS CISPLATIN, ADRIAMYCIN, ETOPOSIDE ALTERNATING WITH CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE AND LOMUSTINE, Annals of oncology, 6(1), 1995, pp. 41-48
THE PROJECTED CHIRAL SOLITON MODEL WITH VECTOR-MESONS
Authors: ARRIOLA ER ALBERTO P GOEKE K URBANO JN
Citation: Er. Arriola et al., THE PROJECTED CHIRAL SOLITON MODEL WITH VECTOR-MESONS, Nuclear physics. A, 591(4), 1995, pp. 561-605
HUMAN RECOMBINANT IL-4 DECREASES THE EMERGENCE OF NONSPECIFIC CYTOLYTIC CELLS AND FAVORS THE APPEARANCE OF MEMORY CELLS (CD4(-2-DRIVEN DEVELOPMENT OF CYTOTOXIC T-LYMPHOCYTES AGAINST AUTOLOGOUS OVARIAN TUMOR-CELLS()CD45RO(+)) IN THE IL)
Authors: ROTH AD DUPUIS S ALBERTO P
Citation: Ad. Roth et al., HUMAN RECOMBINANT IL-4 DECREASES THE EMERGENCE OF NONSPECIFIC CYTOLYTIC CELLS AND FAVORS THE APPEARANCE OF MEMORY CELLS (CD4(-2-DRIVEN DEVELOPMENT OF CYTOTOXIC T-LYMPHOCYTES AGAINST AUTOLOGOUS OVARIAN TUMOR-CELLS()CD45RO(+)) IN THE IL), Clinical and experimental immunology, 101(2), 1995, pp. 362-368
DEFINITION OF DOSE INTENSITY (DI), AVERAG E RELATIVE-DI AND EFFECTIVE-DI
Authors: ALBERTO P
Citation: P. Alberto, DEFINITION OF DOSE INTENSITY (DI), AVERAG E RELATIVE-DI AND EFFECTIVE-DI, Bulletin du cancer, 82, 1995, pp. 3-8
TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN A PATIENT TREATEDWITH CLADRIBINE (2-CHLORODEOXYADENOSINE) - DEMONSTRATION OF EXOGENOUSDNA IN VARIOUS TISSUE-EXTRACTS BY PCR ANALYSIS
Authors: ZULIAN GB ROUX E TIERCY JM EXTERMANN M DIEBOLDBERGER S REYMOND JM HELG C ZUBLER R BETTICHER DC ALBERTO P JEANNET M CHAPUIS B
Citation: Gb. Zulian et al., TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN A PATIENT TREATEDWITH CLADRIBINE (2-CHLORODEOXYADENOSINE) - DEMONSTRATION OF EXOGENOUSDNA IN VARIOUS TISSUE-EXTRACTS BY PCR ANALYSIS, British Journal of Haematology, 89(1), 1995, pp. 83-89
FIRST-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE (HD) WITH VINCRISTINE, ETOPOSIDE, MITOXANTRONE AND PREDNISONE (VEMP)
Authors: ZULIAN GB MERMILLOD B ITEN PA ALBERTO P
Citation: Gb. Zulian et al., FIRST-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE (HD) WITH VINCRISTINE, ETOPOSIDE, MITOXANTRONE AND PREDNISONE (VEMP), Blood, 86(10), 1995, pp. 3295-3295
Risultati: 1-25 | 26-39